Research To Practice | Oncology Videos
Podcast image
Metastatic Breast Cancer | Improving Outcomes with First-Line Endocrine-Based Therapy for Patients with HR-Positive, HER2-Negative Metastatic Breast Cancer
59 mins; November 01, 2024
Mantle Cell Lymphoma | Michael Wang, MD
53 mins; October 30, 2024
Mantle Cell Lymphoma | Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
57 mins; October 30, 2024
HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer (Companion Faculty Lecture)
22 mins; October 25, 2024
HR-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Potential Role of PROTAC ER Degraders in Therapy for HR-Positive Metastatic Breast Cancer
45 mins; October 25, 2024
Chronic Myeloid Leukemia | Jorge Cortes, MD
27 mins; October 24, 2024
Chronic Myeloid Leukemia | Practical Perspectives: Current Management of Chronic Myeloid Leukemia
109 hours 2 mins; October 24, 2024
Small Cell Lung Cancer | The Implications of Recent Datasets for the Current and Future Management of Small Cell Lung Cancer — A 2024 World Conference on Lung Cancer Review
42 mins; October 23, 2024
Desmoid Tumors | Practical Perspectives: Optimizing Diagnosis and Treatment for Patients with Desmoid Tumors
59 mins; October 18, 2024
Peripheral T-Cell Lymphoma | Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma (Companion Faculty Lecture)
25 mins; October 17, 2024
Peripheral T-Cell Lymphoma | Oncology Today with Dr Neil Love: Peripheral T-Cell Lymphoma
46 mins; October 17, 2024
Metastatic Non-Small Cell Lung Cancer | The Implications of Recent Datasets for the Current and Future Use of Nontargeted Therapy for Metastatic Non-Small Cell Lung Cancer
60 hours 8 mins; October 16, 2024
Chronic Lymphocytic Leukemia | Meet The Professor: Optimizing the Management of Chronic Lymphocytic Leukemia — Part 1 of a 3-Part Series
58 mins; October 10, 2024
Diffuse Large B-Cell Lymphoma | Data + Perspectives: Clinical Investigators Discuss the Current and Future Management of Diffuse Large B-Cell Lymphoma
60 hours 32 mins; October 09, 2024
Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR | The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with Actionable Targets Beyond EGFR
58 mins; October 08, 2024
Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia | Data + Perspectives: Clinical Investigators Discuss the Role of CAR T-Cell Therapy for Patients with Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
59 mins; October 04, 2024
Non-Small Cell Lung Cancer with EGFR Mutations | The Implications of Recent Datasets for the Current and Future Management of Non-Small Cell Lung Cancer with EGFR Mutations
58 mins; October 02, 2024
Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer (Companion Faculty Lecture)
27 mins; September 25, 2024
Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Management of Metastatic BRCA-Negative, Triple-Negative Breast Cancer
49 mins; September 25, 2024
Biliary Tract Cancers | Striving for Consensus: Optimizing the Current and Future Management of Biliary Tract Cancers
134 hours 33 mins; September 20, 2024
Neuroendocrine Tumors | Pamela Kunz, MD
26 mins; September 19, 2024
Neuroendocrine Tumors | Simron Singh, MD, MPH
22 mins; September 19, 2024
Neuroendocrine Tumors | Inside the Issue: Optimizing the Diagnosis and Treatment of Neuroendocrine Tumors
59 mins; September 19, 2024
Gastrointestinal Cancers | John Strickler, MD
56 mins; September 13, 2024
Gastrointestinal Cancers | Inside the Issue: Integrating HER2-Targeted Strategies into the Management of Gastrointestinal Cancers
60 hours 59 mins; September 13, 2024
Gastrointestinal Cancers | Tanios Bekaii-Saab, MD
32 mins; September 13, 2024
Non-Small Cell Lung Cancer with an EGFR Mutation | Striving for Consensus: Current and Future Management of Non-Small Cell Lung Cancer with an EGFR Mutation
123 hours 1 min; September 12, 2024
Dedifferentiated Liposarcoma | Oncology Today with Dr Neil Love: Optimizing the Management of Dedifferentiated Liposarcoma
75 hours 0 mins; September 10, 2024
HR-Positive and Triple-Negative Metastatic Breast Cancer | Inside the Issue: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
62 hours 35 mins; September 06, 2024
HR-Positive and Triple-Negative Metastatic Breast Cancer | Professor Peter Schmid, FRCP, MD, PhD
48 mins; September 06, 2024
HR-Positive and Triple-Negative Metastatic Breast Cancer | Sara M Tolaney, MD, MPH
28 mins; September 06, 2024
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer (Companion Faculty Lecture)
43 mins; August 30, 2024
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Management of Metastatic Urothelial Bladder Cancer
30 mins; August 30, 2024
Breast Cancer | Oncology Today with Dr Neil Love: Special Edition — Key Presentations on Breast Cancer from the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
75 hours 44 mins; August 29, 2024
Metastatic Breast Cancer | Oncology Today with Dr Neil Love: An interview with Professor Giuseppe Curigliano, MD, PhD — Management of Metastatic Breast Cancer
45 mins; August 23, 2024
Ovarian and Endometrial Cancer | Oncology Today with Dr Neil Love: An interview with Angeles Alvarez Secord, MD, MHSc — Management of Ovarian and Endometrial Cancer
52 mins; August 22, 2024
Non-Small Cell Lung Cancer | Professor Solange Peters, MD, PhD
39 mins; August 21, 2024
Non-Small Cell Lung Cancer | Professor Ben Solomon, MBBS, PhD
21 mins; August 21, 2024
Non-Small Cell Lung Cancer | Inside the Issue: Integrating ALK-Targeted Therapy into the Management of Localized Non-Small Cell Lung Cancer
61 hours 24 mins; August 21, 2024
Breast Cancer | Oncology Today with Dr Neil Love: Integrating Antibody-Drug Conjugates into the Management of HR-Positive and Triple-Negative Metastatic Breast Cancer
54 mins; August 16, 2024
Lung Cancer | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Lung Cancer
61 hours 44 mins; August 14, 2024
Multiple Myeloma | Jesús G Berdeja, MD
60 hours 33 mins; August 12, 2024
Multiple Myeloma | Thomas Martin, MD
48 mins; August 12, 2024
Multiple Myeloma | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Multiple Myeloma
62 hours 4 mins; August 12, 2024
Skin Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Melanoma and Nonmelanoma Skin Cancers
59 mins; August 09, 2024
Breast Cancer | Individualizing the Selection of First-Line Therapy for Patients with Hormone Receptor-Positive Metastatic Breast Cancer
74 hours 37 mins; August 07, 2024
Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Immunotherapy and Other Nontargeted Approaches for Lung Cancer
60 hours 54 mins; August 05, 2024
Prostate Cancer | Oncology Today with Dr Neil Love: An interview with Matthew R Smith, MD, PhD — Management of Prostate Cancer
53 mins; August 02, 2024
HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer
23 mins; July 31, 2024
HER2-Low Breast Cancer | Oncology Today with Dr Neil Love: Optimizing the Identification of HER2-Low Breast Cancer (Companion Faculty Lecture)
39 mins; July 31, 2024
Gynecologic Oncology | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Gynecologic Oncology
59 mins; July 26, 2024
Non-Small Cell Lung Cancer | Oncology Today with Dr Neil Love: An interview with Jonathan W Goldman, MD — Management of Non-Small Cell Lung Cancer with an EGFR Mutation
47 mins; July 25, 2024
Melanoma and Nonmelanoma Skin Cancers | Investigator Perspectives on Available Research and Challenging Questions in Melanoma and Nonmelanoma Skin Cancers: A Post-ASCO 2024 Annual Review
66 hours 9 mins; July 19, 2024
Renal Cell Carcinoma | Investigator Perspectives on Available Research and Challenging Questions in Renal Cell Carcinoma: A Post-ASCO Annual Review
62 hours 26 mins; July 18, 2024
Colorectal Cancer | RTP Live from Chicago: Investigator Perspectives on Recent Advances and Challenging Questions in the Management of Colorectal Cancer
62 hours 37 mins; July 16, 2024
Lymphoma | RTP Live from Chicago: Investigator Perspectives on the Role of Bispecific Antibodies in the Management of Lymphoma
60 hours 50 mins; July 12, 2024
Triple-Negative Breast Cancer | What Clinicians Want to Know About the Management of Triple-Negative Breast Cancer
63 hours 59 mins; July 11, 2024
Multiple Myeloma | Breakfast with the Investigators: New Advances in Multiple Myeloma
60 hours 1 min; July 09, 2024
Lung Cancer | Breakfast with the Investigators: Current and Emerging Role of Antibody-Drug Conjugates in the Treatment of Lung Cancer
59 mins; July 08, 2024
Myelofibrosis | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Myelofibrosis
60 hours 7 mins; July 02, 2024
Prostate Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Prostate Cancer
124 hours 25 mins; July 01, 2024
Metastatic Breast Cancer | What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Metastatic Breast Cancer
119 hours 33 mins; June 28, 2024
Ovarian and Endometrial Cancer | Meet The Professors Live: Clinical Investigators Provide Perspectives on Actual Cases of Patients with Ovarian and Endometrial Cancer
117 hours 16 mins; June 27, 2024
Antibody-Drug Conjugates | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Optimal Implementation of Antibody-Drug Conjugates
89 hours 14 mins; June 26, 2024
Hepatobiliary Cancers | Lunch with the Investigators: Hepatobiliary Cancers
62 hours 32 mins; June 25, 2024
Non-Small Cell Lung Cancer | Second Opinion: Investigators Discuss How They Apply Available Clinical Research in the Care of Patients with Non-Small Cell Lung Cancer with an EGFR Mutation
119 hours 49 mins; June 21, 2024
Hormone Receptor-Positive Breast Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hormonal Therapy for Hormone Receptor-Positive Breast Cancer
122 hours 23 mins; June 20, 2024
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Clinical Update on the Current Management of Advanced Urothelial Bladder Cancer'
83 hours 27 mins; June 18, 2024
Chronic Lymphocytic Leukemia and Lymphoma | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Chronic Lymphocytic Leukemia and Bispecific Antibodies in the Management of Lymphoma
119 hours 48 mins; June 14, 2024
Breast Cancer | Striving for Consensus: Exploring the Current Role of Ovarian Suppression in the Management of Breast Cancer
155 hours 29 mins; June 13, 2024
Non-Small Cell Lung Cancer | Justin F Gainor, MD
52 mins; June 12, 2024
Non-Small Cell Lung Cancer | Karen Reckamp, MD, MS
34 mins; June 12, 2024
Non-Small Cell Lung Cancer | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Targeted Therapy for Non-Small Cell Lung Cancer
60 hours 49 mins; June 12, 2024
Gastroesophageal and Colorectal Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Gastroesophageal and Colorectal Cancers
120 hours 22 mins; June 10, 2024
Urothelial Bladder Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Urothelial Bladder Cancer
62 hours 32 mins; June 07, 2024
Myelofibrosis | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Myelofibrosis
90 hours 32 mins; June 06, 2024
Ovarian Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Ovarian Cancer
92 hours 21 mins; June 04, 2024
Head and Neck Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Head and Neck Cancer
91 hours 8 mins; May 31, 2024
Prostate Cancer | Second Opinion: Urologic Oncology Investigators Discuss How They Apply Clinical Research in the Care of Patients with Prostate Cancer
119 hours 31 mins; May 30, 2024
Lymphoma | Oncology Today with Dr Neil Love: Key Presentations on Lymphoma from Recent Major Conferences
76 hours 46 mins; May 29, 2024
Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Companion Faculty Lecture)
35 mins; May 28, 2024
Acute Lymphoblastic Leukemia | Oncology Today with Dr Neil Love: Recent Advances in the Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
33 mins; May 28, 2024
Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma (Companion Faculty Lecture)
29 mins; May 24, 2024
Multiple Myeloma | Oncology Today with Dr Neil Love: Bispecific Antibodies in the Management of Multiple Myeloma
41 mins; May 24, 2024
Hepatobiliary Cancers | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Hepatobiliary Cancers
89 hours 58 mins; May 23, 2024
HER2-Positive Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Risk of Recurrence and Related Management for Patients with Localized HER2-Positive Breast Cancer
76 hours 17 mins; May 21, 2024
Endometrial Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Endometrial Cancer
90 hours 22 mins; May 17, 2024
Prostate Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Prostate Cancer
59 mins; May 16, 2024
Acute Myeloid Leukemia | Naval Daver, MD
41 mins; May 14, 2024
Acute Myeloid Leukemia | Courtney D DiNardo, MD, MSCE
44 mins; May 14, 2024
Acute Myeloid Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Acute Myeloid Leukemia
62 hours 8 mins; May 14, 2024
Non-Small Cell Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation
89 hours 8 mins; May 10, 2024
Metastatic Triple-Negative Breast Cancer | Virtual Case Library: Metastatic Triple-Negative Breast Cancer
132 hours 44 mins; May 09, 2024
Urothelial Bladder Cancer | Oncology Today with Dr Neil Love: Role of HER2-Directed Therapy in the Treatment of HER2-Expressing Urothelial Bladder Cancer — Part 3 of a Special 3-Part Edition
67 hours 30 mins; May 07, 2024
Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer (Companion Faculty Lecture)
63 hours 30 mins; May 03, 2024
Gastroesophageal Cancer | Year in Review: Novel Treatments and Strategies in Gastroesophageal Cancer
59 mins; May 03, 2024
Myelofibrosis | Meet The Professor: Optimizing the Management of Myelofibrosis — Part 2 of a 2-Part Series
60 hours 55 mins; May 02, 2024
Endometrial Cancer | Consensus or Controversy? Clinical Investigators Provide Perspectives on the Current and Future Management of Endometrial Cancer
88 hours 43 mins; May 01, 2024
Paroxysmal Nocturnal Hemoglobinuria | Striving for Consensus: Current and Future Management of Paroxysmal Nocturnal Hemoglobinuria
97 hours 2 mins; April 26, 2024
Prostate Cancer | Oncology Today with Dr Neil Love: Special Edition – Prostate Cancer Updates from a CME Program Held at the 2024 Genitourinary Cancers Symposium
59 mins; April 25, 2024